Anthony Quinn
Director/Miembro de la Junta en GENERATION BIO CO. .
Fortuna: 485 609 $ al 30/04/2024
Origen de la red de primer grado Anthony Quinn.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 37 | |
Newcastle University
33
| College/University | Other Consumer Services | 33 |
| Extinct | Biotechnology | 25 | |
| Public Company | Biotechnology | 25 | |
| Public Company | Pharmaceuticals: Major | 21 | |
University Of Dundee
18
| College/University | Other Consumer Services | 18 |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Anthony Quinn a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Private Equity Investor Consultant / Advisor Consultant / Advisor Consultant / Advisor Private Equity Investor Consultant / Advisor Consultant / Advisor Consultant / Advisor | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Director/Board Member Undergraduate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Founder Chief Executive Officer Investor Relations Contact Founder Chief Tech/Sci/R&D Officer | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Chief Executive Officer Private Equity Investor Private Equity Investor | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Compliance Officer | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Public Communications Contact Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
| MODERNA, INC. | Biotechnology | Director/Board Member Founder Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| KINIKSA PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
| AXCA HEALPAR | Biotechnology | Corporate Officer/Principal Founder Founder | |
| BIOGEN INC. | Pharmaceuticals: Major | General Counsel Sales & Marketing Director/Board Member | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer Consultant / Advisor Corporate Officer/Principal | |
| RUBIUS THERAPEUTICS | Biotechnology | Founder Director/Board Member Chief Executive Officer | |
| CELGENE | Biotechnology | Director/Board Member Corporate Officer/Principal Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Princeton University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member Corporate Officer/Principal | |
| DYAX CORP. | Pharmaceuticals: Major | Chief Administrative Officer Chief Executive Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Indigo Ag, Inc.
 Indigo Ag, Inc. BiotechnologyHealth Technology Indigo Ag, Inc. provides microbial solutions. The company was founded by Noubar Afeyan, David A. Berry, and Geoffrey von Maltzahn in 2013 and is headquartered in Charlestown, MA. | Biotechnology | Founder Founder | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| THERMO FISHER SCIENTIFIC | Medical Specialties | Director of Finance/CFO Public Communications Contact | |
Inzen Therapeutics, Inc.
 Inzen Therapeutics, Inc. BiotechnologyHealth Technology Part of Sonata Therapeutics, Inc., Inzen Therapeutics, Inc. is discovering and developing a novel class of medicines based on thanokine biology. The company is based in Cambridge, MA. Thanokine biology offers the potential for unprecedented approaches to prevent and treat cancer, fibrotic disorders, immune-inflammatory disorders, metabolic disorders, and degenerative diseases. Inzen's thanokine product platform applies advances in mass spectrometry and machine learning, novel probes, unique assays, genetic and chemical biological technologies to characterize thanokine biology at scale and create drug candidates. Inzen Therapeutics harnesses signals of the cellular microenvironment to treat serious diseases. The company was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability. | Biotechnology | Director/Board Member Director/Board Member | |
| ACADIA PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Founder | |
| The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Hong Kong Institution of Engineers
 Hong Kong Institution of Engineers Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institution of Engineers operates as a professional membership organization. The non-profit company is based in Hong Kong, Hong Kong. The CEO of the Chinese company is Wing Hang Sit. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Masters Business Admin Undergraduate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| EPIZYME, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer | |
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD. | Drugstore Chains | Director/Board Member Corporate Officer/Principal | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| University of California San Diego | College/University | Graduate Degree Doctorate Degree | |
| VIGIL NEUROSCIENCE, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
| SERES THERAPEUTICS, INC. | Biotechnology | Founder Founder | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SANA BIOTECHNOLOGY, INC. | Biotechnology | Founder Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 49 |
| Dinamarca | 2 |
| Hong-Kong | 2 |
Sectorial
| Health Technology | 34 |
| Consumer Services | 11 |
| Finance | 5 |
| Commercial Services | 3 |
| Retail Trade | 2 |
Operativa
| Director/Board Member | 476 |
| Corporate Officer/Principal | 196 |
| Independent Dir/Board Member | 145 |
| Chairman | 91 |
| Director of Finance/CFO | 84 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Michael Bonney | 32 |
| Thomas Tisch | 27 |
| Theo Melas-Kyriazi | 26 |
| Charles Rowland | 25 |
| Justin Llewellyn Gareth Lewis | 25 |
| Alison Lawton | 24 |
| Jason Rhodes | 24 |
| Stephen DiPalma | 24 |
| Riyadh Salem Ali Ahmed Al-Edrissi | 23 |
| V. Lawlis | 21 |
| Ben Keswick Keswick | 21 |
| Jeff Jonas | 21 |
| Bonnie Bassler | 20 |
| Andrew Peter Davison | 19 |
- Bolsa de valores
- Insiders
- Anthony Quinn
- Conexiones Empresas
